Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register

The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy

Maxime Dougados, Sjef van der Linden, Roger Juhlin et al. · Arthritis & Rheumatism · 1991 · 2.3K citations

Medicine, Clinical Sciences, Internal Medicine +9

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

Filip Baert, Maja Noman, Séverine Vermeire et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

Philip J. Mease, Bernard S. Goffe, James M. Metz et al. · The Lancet · 2000 · 1.5K citations

Medicine, Immunology, Pharmacotherapy +6

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 905 citations

Medicine, Pharmacology, Pharmacotherapy +15

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

Christian Antoni, Arthur Kavanaugh, Bruce Kirkham et al. · Arthritis & Rheumatism · 2005 · 643 citations

Medicine, Clinical Sciences, Pharmacotherapy +17